RING
DEAD

Serial Number

88744777

Owner

RING THERAPEUTICS, INC.

Attorney

Christina M. Licursi, Esq.

Filing Date

Jan 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RING Trademark

Serial Number: 88744777

RING is a trademark filed by RING THERAPEUTICS, INC. on January 2, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

RING THERAPEUTICS, INC. (19 trademarks)

CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

January 2, 2020

Registration Date

Not Registered

Published for Opposition

July 7, 2020

Goods & Services

encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of disease, namely, rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; pharmaceutical preparations for use in gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 2, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 2, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2023 EXRA
SOU EXTENSION 5 GRANTED
Mar 9, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 9, 2023 AITU
SOU EXTENSION 5 FILED
Feb 24, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Feb 24, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 1, 2022 EXRA
SOU EXTENSION 4 GRANTED
Aug 30, 2022 EX4G
SOU EXTENSION 4 FILED
Aug 30, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 30, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2022 EXRA
SOU EXTENSION 3 GRANTED
Feb 28, 2022 EX3G
SOU EXTENSION 3 FILED
Feb 28, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2021 EXRA
SOU EXTENSION 2 GRANTED
Aug 25, 2021 EX2G
SOU EXTENSION 2 FILED
Aug 25, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 25, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2021 EXRA
SOU EXTENSION 1 GRANTED
Mar 1, 2021 EX1G
SOU EXTENSION 1 FILED
Mar 1, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 1, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 1, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 26, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 9, 2020 NWOS